Filing Signals

Source: SEC EDGAR Compiled 2026-09-14 08:28 UTC All 21 checks passing

← All events

Regenerative Medical Technology Group Inc.

CIK 1760026 RMTG·Retail Trade · All EDGAR filings ↗

Progression

  1. Late filing NT 10-K
  2. Revenue recognition change 10-K +43d
Refine
Form
An amendment is grouped with the report it amends; every 12b-25 notice is one group

Late filing Filing comparison

Regenerative Medical Technology Group Inc. told the SEC it could not file its quarterly report on time

Does not expect a significant change in results. Filed on the statutory due date.

The Registrant has been unable, without unreasonable effort or expense, to timely compile all information for the financial statements and related disclosures required to be included in its Quarterly Report on Form 10-Q for the quarter ended June 30, 2026.
Evidence
Anticipates significant change
No
Days past due date
0
Routine
Yes
Severity
normal
Source
Form 12b-25 (notification of late filing)
Stated reason
The Registrant has been unable, without unreasonable effort or expense, to timely compile all information for the financial statements and related disclosures required to be included in its Quarterly Report on Form 10-Q for the quarter ended June 30, 2026.
Why
The company told the SEC it could not file a periodic report on time, using Form 12b-25.

Source filing ↗

Revenue recognition change beta Filing comparison

Regenerative Medical Technology Group Inc. changed its revenue recognition disclosure

The performance obligation is satisfied upon completion of the training seminar and delivery of the related certification and materials.
Evidence
New language
The performance obligation is satisfied upon completion of the training seminar and delivery of the related certification and materials., Revenue is recognized at the point in time the seminar is completed and control of the training services has transferred to the customer.
Prior filed
2025-11-19
Prior form
10-Q
Similarity
0.009
Source
revenue recognition note comparison
Threshold
0.6
Why
The revenue recognition policy disclosure changed materially from the previous comparable filing.

Language present now, absent from the prior filing:

  • The performance obligation is satisfied upon completion of the training seminar and delivery of the related certification and materials.
  • Revenue is recognized at the point in time the seminar is completed and control of the training services has transferred to the customer.

Source filing ↗ Prior filing ↗

Late filing Filing comparison

Regenerative Medical Technology Group Inc. told the SEC it could not file its quarterly report on time

Does not expect a significant change in results. Filed on the statutory due date.

The Registrant has been unable, without unreasonable effort or expense, to timely compile all information for the financial statements and related disclosures required to be included in its Quarterly Report on Form 10-Q for the quarter ended March 31, 2026.
Evidence
Anticipates significant change
No
Days past due date
0
Other periodic reports filed
Yes
Routine
Yes
Severity
normal
Source
Form 12b-25 (notification of late filing)
Stated reason
The Registrant has been unable, without unreasonable effort or expense, to timely compile all information for the financial statements and related disclosures required to be included in its Quarterly Report on Form 10-Q for the quarter ended March 31, 2026.
Why
The company told the SEC it could not file a periodic report on time, using Form 12b-25.

Source filing ↗

Revenue recognition change beta Filing comparison

Regenerative Medical Technology Group Inc. changed its revenue recognition disclosure

The performance obligation is satisfied upon completion of the training seminar and delivery of the related certification and materials.
Evidence
New language
The performance obligation is satisfied upon completion of the training seminar and delivery of the related certification and materials., Revenue is recognized at the point in time the seminar is completed and control of the training services has transferred to the customer.
Prior filed
2025-04-15
Prior form
10-K
Similarity
0.009
Source
revenue recognition note comparison
Threshold
0.6
Why
The revenue recognition policy disclosure changed materially from the previous comparable filing.

Language present now, absent from the prior filing:

  • The performance obligation is satisfied upon completion of the training seminar and delivery of the related certification and materials.
  • Revenue is recognized at the point in time the seminar is completed and control of the training services has transferred to the customer.

Source filing ↗ Prior filing ↗

Late filing elevated Filing comparison

Regenerative Medical Technology Group Inc. told the SEC it could not file its annual report on time

Does not expect a significant change in results. 1 day past the statutory due date.

The Registrant has been unable, without unreasonable effort or expense, to timely compile all information for the financial statements and related disclosures required to be included in its Annual Report on Form 10-K for the year ended December 31, 2025.
Evidence
Anticipates significant change
No
Days past due date
1
Other periodic reports filed
Yes
Routine
No
Severity
elevated
Source
Form 12b-25 (notification of late filing)
Stated reason
The Registrant has been unable, without unreasonable effort or expense, to timely compile all information for the financial statements and related disclosures required to be included in its Annual Report on Form 10-K for the year ended December 31, 2025.
Why
The company told the SEC it could not file a periodic report on time, using Form 12b-25.

Source filing ↗